Bridgeway Capital Management’s Neuropace NPCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-30,400
| Closed | -$374K | – | 1231 |
|
|
2025
Q1 | $374K | Hold |
30,400
| – | – | 0.01% | 799 |
|
|
2024
Q4 | $340K | Sell |
30,400
-2,800
| -8% | -$31.3K | 0.01% | 897 |
|
|
2024
Q3 | $231K | Hold |
33,200
| – | – | 0.01% | 1029 |
|
|
2024
Q2 | $251K | Hold |
33,200
| – | – | 0.01% | 1000 |
|
|
2024
Q1 | $438K | Sell |
33,200
-700
| -2% | -$9.24K | 0.01% | 953 |
|
|
2023
Q4 | $350K | Sell |
33,900
-26,148
| -44% | -$270K | 0.01% | 1035 |
|
|
2023
Q3 | $584K | Hold |
60,048
| – | – | 0.01% | 839 |
|
|
2023
Q2 | $270K | Buy |
60,048
+8,400
| +16% | +$37.7K | 0.01% | 1069 |
|
|
2023
Q1 | $240K | Buy |
51,648
+20,000
| +63% | +$92.8K | 0.01% | 1070 |
|
|
2022
Q4 | $47.2K | Hold |
31,648
| – | – | ﹤0.01% | 1303 |
|
|
2022
Q3 | $119K | Buy |
31,648
+5,500
| +21% | +$20.7K | ﹤0.01% | 1246 |
|
|
2022
Q2 | $129K | Buy |
+26,148
| New | +$129K | ﹤0.01% | 1178 |
|